ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,565.95
      1.11%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inovio Pharmaceuticals Inc New (INO)

      7. Inovio Pharmaceuticals Inc New (INO) News

      INO

      Inovio Pharmaceuticals (INO)

      Inovio Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INO
      DateTimeSourceHeadlineSymbolCompany
      04/28/20238:00AMPR Newswire (US)INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:INOInovio Pharmaceuticals Inc New
      04/27/20238:00AMPR Newswire (US)INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis at COSM 2023NASDAQ:INOInovio Pharmaceuticals Inc New
      04/26/20238:00AMPR Newswire (US)European Committee for Orphan Medicinal Products Provides Positive Opinion on INOVIO's Application for Orphan Drug Designation for INO-3107NASDAQ:INOInovio Pharmaceuticals Inc New
      04/17/20238:00AMPR Newswire (US)Data from Phase 1b trial with INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) presented at ECCMID 2023NASDAQ:INOInovio Pharmaceuticals Inc New
      04/12/20238:00AMPR Newswire (US)INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) at ECCMID 2023NASDAQ:INOInovio Pharmaceuticals Inc New
      04/04/20236:06AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INOInovio Pharmaceuticals Inc New
      04/03/20238:00AMPR Newswire (US)INOVIO Reports Inducement Grant Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
      03/31/20234:35PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/28/20235:05PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/13/20235:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/13/20235:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/13/20235:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/03/20238:00AMPR Newswire (US)INOVIO to Present at the Oppenheimer 33rd Annual Healthcare ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
      03/01/20235:09PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/01/20234:32PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/01/20234:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/01/20234:05PMPR Newswire (US)INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
      02/28/20235:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      02/28/20235:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      02/16/20238:00AMPR Newswire (US)INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:INOInovio Pharmaceuticals Inc New
      02/15/20238:00AMPR Newswire (US)INOVIO to Report Fourth Quarter and Year-End 2022 Financial Results on March 1, 2023NASDAQ:INOInovio Pharmaceuticals Inc New
      02/09/202311:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INOInovio Pharmaceuticals Inc New
      02/03/20238:00AMPR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
      02/02/20238:00AMPR Newswire (US)INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®)NASDAQ:INOInovio Pharmaceuticals Inc New
      01/31/20238:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      01/31/20238:00AMPR Newswire (US)INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine CandidatesNASDAQ:INOInovio Pharmaceuticals Inc New
      01/17/20234:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      11/17/20224:30PMPR Newswire (US)INOVIO Provides an Update on Lassa Fever and MERS ProgramsNASDAQ:INOInovio Pharmaceuticals Inc New
      11/10/20228:48PMTipRanksRBC Capital Reaffirms Their Hold Rating on Inovio Pharmaceuticals (INO)NASDAQ:INOInovio Pharmaceuticals Inc New
      11/08/20224:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
       Showing the most relevant articles for your search:NASDAQ:INO